Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant and obesity in trigeminovascular reactivity study
NL-OMON60412Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rimegepant in migraine, sponsored by Erasmus MC. Started Mar 2025; status: completed.
02
Drugs
rimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NL-OMON60412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60412.